评价Hedera物种作为草药原料
İçim Gökkaya1, Nurdan Yazici1, Gökçe Seyhan2
1Department of Pharmacognosy, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Turkey.
Natural product research
|July 1, 2024
概括
黑 (Hedera colchica) 显示出呼吸道炎症的潜力,为黑螺旋 (Hedera helix) 提供了一个强有力的替代品. 它的提取物含有有益的沙素,,酸和hesperidin,以增强治疗效果.
科学领域:
- 药理学是指药理学,即药理学是指药理学.
- 植物化学 植物化学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 传统上使用Hedera物种治疗呼吸道疾病.
- 需要替代植物性治疗炎症疾病.
- 与Hedera helix相比,对Hedera colchica的治疗潜力进行的研究有限.
研究的目的:
- 评估Hedera colchica作为用于呼吸道炎症的Hedera螺旋的替代品.
- 为了识别和量化Hedera colchica提取物中的关键生物活性化合物.
- 为了评估Hedera colchica提取物的COX-2抑制作用.
主要方法:
- 基于沙素和含量的Hedera colchica提取物的制备和表征.
- 使用液体染色学-质谱学/质谱学 (LC-MS/MS) 的化学分析.
- 选择性COX-2抑制活性的评估.
主要成果:
- 已识别的提取物是C3S (高素) 和C1F (高).
- 对C1F提取物的LC-MS/MS分析显示了高度的酸和hesperidin.
- C1F提取物显示出显著的COX-2抑制作用.
结论:
- 黑 (Hedera colchica) 具有强大的抗炎性质,可能超过黑螺旋体的抗炎性质.
- 沙素和化合物,包括酸和hesperidin,有助于治疗疗效.
- 优化的Hedera colchica提取物为治疗上呼吸道和慢性支气管炎症疾病提供了一个有希望的替代方案.
更多相关视频
06:44Author Spotlight: Developing Identification Methods for Rhodiola crenulata and Investigating Its Resource Distribution and Pharmacological Effects
Published on: October 27, 2023
628
07:16Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry
Published on: February 2, 2024
550
相关概念视频
Therapeutic Index
7.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.4K
Hazard Ratio
756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
756
